221 related articles for article (PubMed ID: 33279858)
21. Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.
Tang Z; Wei G; Zhang L; Xu Z
Mol Med Rep; 2019 Jun; 19(6):4806-4818. PubMed ID: 31059106
[TBL] [Abstract][Full Text] [Related]
22. Identification of Potential Prostate Cancer-Related Pseudogenes Based on Competitive Endogenous RNA Network Hypothesis.
Jiang T; Guo J; Hu Z; Zhao M; Gu Z; Miao S
Med Sci Monit; 2018 Jun; 24():4213-4239. PubMed ID: 29923546
[TBL] [Abstract][Full Text] [Related]
23. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Yu J; Mao W; Xu B; Chen M
Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
[TBL] [Abstract][Full Text] [Related]
24. A four-gene signature associated with clinical features can better predict prognosis in prostate cancer.
Yuan P; Ling L; Fan Q; Gao X; Sun T; Miao J; Yuan X; Liu J; Liu B
Cancer Med; 2020 Nov; 9(21):8202-8215. PubMed ID: 32924329
[TBL] [Abstract][Full Text] [Related]
25. The m6A methylation regulator-based signature for predicting the prognosis of prostate cancer.
Wang J; Lin H; Zhou M; Xiang Q; Deng Y; Luo L; Liu Y; Zhu Z; Zhao Z
Future Oncol; 2020 Oct; 16(30):2421-2432. PubMed ID: 32687727
[No Abstract] [Full Text] [Related]
26. Exploring prognostic potential of long noncoding RNAs in colorectal cancer based on a competing endogenous RNA network.
Yang ZD; Kang H
World J Gastroenterol; 2020 Mar; 26(12):1298-1316. PubMed ID: 32256018
[TBL] [Abstract][Full Text] [Related]
27. Pan-cancer characterization of long non-coding RNA and DNA methylation mediated transcriptional dysregulation.
Yang Z; Xu F; Wang H; Teschendorff AE; Xie F; He Y
EBioMedicine; 2021 Jun; 68():103399. PubMed ID: 34044218
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
29. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
30. SP1-mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR-377 to facilitate prostate cancer progression through regulation of ZIC5.
Wang ZY; Duan Y; Wang P
J Cell Physiol; 2020 Apr; 235(4):3916-3927. PubMed ID: 31608997
[TBL] [Abstract][Full Text] [Related]
31. Identification of Long Non-Coding RNA Expression Profiles and Co-Expression Genes in Thyroid Carcinoma Based on The Cancer Genome Atlas (TCGA) Database.
Zhang Y; Jin T; Shen H; Yan J; Guan M; Jin X
Med Sci Monit; 2019 Dec; 25():9752-9769. PubMed ID: 31856144
[TBL] [Abstract][Full Text] [Related]
32. Long Noncoding RNA
Misawa A; Kondo Y; Takei H; Takizawa T
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33514011
[TBL] [Abstract][Full Text] [Related]
33. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
34. The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.
Matondo A; Jo YH; Shahid M; Choi TG; Nguyen MN; Nguyen NNY; Akter S; Kang I; Ha J; Maeng CH; Kim SY; Lee JS; Kim J; Kim SS
Sci Rep; 2017 Aug; 7(1):9689. PubMed ID: 28851888
[TBL] [Abstract][Full Text] [Related]
35. Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.
Shukla S; Zhang X; Niknafs YS; Xiao L; Mehra R; Cieślik M; Ross A; Schaeffer E; Malik B; Guo S; Freier SM; Bui HH; Siddiqui J; Jing X; Cao X; Dhanasekaran SM; Feng FY; Chinnaiyan AM; Malik R
Neoplasia; 2016 Aug; 18(8):489-99. PubMed ID: 27566105
[TBL] [Abstract][Full Text] [Related]
36. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide analysis of long noncoding RNA (lncRNA) expression in colorectal cancer tissues from patients with liver metastasis.
Chen D; Sun Q; Cheng X; Zhang L; Song W; Zhou D; Lin J; Wang W
Cancer Med; 2016 Jul; 5(7):1629-39. PubMed ID: 27165481
[TBL] [Abstract][Full Text] [Related]
38. Integrative identification of deregulated miRNA/TF-mediated gene regulatory loops and networks in prostate cancer.
Afshar AS; Xu J; Goutsias J
PLoS One; 2014; 9(6):e100806. PubMed ID: 24968068
[TBL] [Abstract][Full Text] [Related]
39. Construction and analysis of a spinal cord injury competitive endogenous RNA network based on the expression data of long noncoding, micro‑ and messenger RNAs.
Wang L; Wang B; Liu J; Quan Z
Mol Med Rep; 2019 Apr; 19(4):3021-3034. PubMed ID: 30816457
[TBL] [Abstract][Full Text] [Related]
40. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
